Assyro AI

Orange Book product · Brand (NDA)

ONZETRA XSAIL

SUMATRIPTAN SUCCINATE

Brand (NDA)NDA 206099RX CURRAX
View SUMATRIPTAN SUCCINATE familyOpen on FDA Orange Book

At a glance

Jan 27, 2016

Approved

Brand (NDA)

Application

Not listed

TE code

18

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 27, 2016

    10 yr 7 mo ago

  2. Patent 11571531 expires

    Listed method-of-use patent (U-1809) expiration.

    Feb 23, 2026

    4 mo ago

  3. Today

  4. Patent 10124132 expires

    Listed drug product patent expiration.

    Mar 06, 2027

    in 9 mo

  5. Patent 10124132 expires

    Listed drug product patent expiration.

    Mar 06, 2027

    in 9 mo

  6. Patent 10124132 expires

    Listed drug product patent expiration.

    Mar 06, 2027

    in 9 mo

  7. Patent 10398859 expires

    Listed drug product patent expiration.

    Dec 19, 2027

    in 1 yr 6 mo

  8. Patent 8875704 expires

    Listed drug product patent expiration.

    Apr 07, 2028

    in 1 yr 10 mo

  9. Patent 10722667 expires

    Listed drug product patent expiration.

    Dec 30, 2028

    in 2 yr 7 mo

  10. Patent 10076615 expires

    Listed method-of-use patent (U-2011) expiration.

    Jul 30, 2029

    in 3 yr 2 mo

  11. Patent 10076615 expires

    Listed method-of-use patent (U-2010) expiration.

    Jul 30, 2029

    in 3 yr 2 mo

  12. Patent 10076615 expires

    Listed method-of-use patent (U-2404) expiration.

    Jul 30, 2029

    in 3 yr 2 mo

  13. Patent 8550073 expires

    Listed drug product patent expiration.

    Oct 22, 2029

    in 3 yr 5 mo

  14. Patent 8899229 expires

    Listed drug product patent expiration.

    Aug 18, 2030

    in 4 yr 3 mo

  15. Patent 9649456 expires

    Listed drug product patent expiration.

    Oct 21, 2030

    in 4 yr 5 mo

  16. Patent 9649456 expires

    Listed drug product patent expiration.

    Oct 21, 2030

    in 4 yr 5 mo

  17. Patent 9649456 expires

    Listed drug product patent expiration.

    Oct 21, 2030

    in 4 yr 5 mo

  18. Patent 8978647 expires

    Listed drug product patent expiration.

    Dec 06, 2030

    in 4 yr 6 mo

  19. Patent 10478574 expires

    Listed method-of-use patent (U-2404) expiration.

    Nov 04, 2033

    in 7 yr 6 mo

  20. Patent 10076614 expires

    Listed drug product patent expiration.

    Oct 20, 2034

    in 8 yr 6 mo

Pharmaceutical detail

Active ingredient

SUMATRIPTAN SUCCINATE

Strength

EQ 11MG BASE

Dosage form

POWDER

Route

NASAL

TE code

Not listed

Application

NDA 206099

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (18)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11571531Feb 23, 20264 mo ago
U-1809
10124132Mar 06, 2027in 9 mo
ProductU-2010
10124132Mar 06, 2027in 9 mo
ProductU-1719
10124132Mar 06, 2027in 9 mo
ProductU-2011
10398859Dec 19, 2027in 1 yr 6 mo
Product
8875704Apr 07, 2028in 1 yr 10 mo
ProductU-1809
10722667Dec 30, 2028in 2 yr 7 mo
Product
10076615Jul 30, 2029in 3 yr 2 mo
U-2011
10076615Jul 30, 2029in 3 yr 2 mo
U-2010
10076615Jul 30, 2029in 3 yr 2 mo
U-2404
8550073Oct 22, 2029in 3 yr 5 mo
Product
8899229Aug 18, 2030in 4 yr 3 mo
Product
9649456Oct 21, 2030in 4 yr 5 mo
ProductU-1719
9649456Oct 21, 2030in 4 yr 5 mo
ProductU-2011
9649456Oct 21, 2030in 4 yr 5 mo
ProductU-2010
8978647Dec 06, 2030in 4 yr 6 mo
Product
10478574Nov 04, 2033in 7 yr 6 mo
U-2404
10076614Oct 20, 2034in 8 yr 6 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo